Molecular staging of early colon cancer on the basis of sentinel node analysis: A multicenter phase II trial

Journal of Clinical Oncology

Volumn 19, Issue 4, 2001, Pages 1128-1136

  Bilchik, A J ^a   Saha, S ^a   Wiese, D ^a   Stonecypher, J A ^a   Wood, T F ^a   Sostrin, S ^a   Turner, R R ^a   Wang, H J ^a   Morton, D L ^a   Hoon, D S B ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; EOSIN; HEMATOXYLIN; TUMOR MARKER;

ARTICLE; CANCER STAGING; CLINICAL TRIAL; COLON CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; METASTASIS; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE BIOPSY; STAINING;

EID: 0035865170     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.4.1128     Document Type: Article

References (32)

1. Cancer statistics, 2000
2. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49: Correlation with long-term survival
3. Micrometastases and survival in stage II colorectal cancer
4. Genetic diagnosis of lymph-node metastasis in colorectal cancer
5. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: An immunohistochemical study
6. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma
7. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins
8. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative colorectal cancer
9. Genetic detection of lymph node micrometastases in patients with colorectal cancer
10. Technical details of intraoperative lymphatic mapping for early stage melanoma
11. Improved axillary staging of breast cancer with sentinel lymphadenectomy
12. Lymphatic mapping and sentinel lymphadenectomy for breast cancer
13. Sentinel lymphadenectomy in thyroid malignant neoplasms
14. Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms
15. Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging
16. Focused examination of sentinel lymph nodes upstages early colorectal carcinoma
17. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay
18. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients
19. Molecular detection of metastatic pancreatic carcinoma cells using a multimarker reverse transcriptase-polymerase chain reaction assay
20. Detection of metastatic breast cancer by beta-hCG polymerase chain reaction
21. Human chorionic gonadotropin-beta subunit gene expression in cultured human fetal and cancer cells of different types and origins
22. The cell dissociation and motility triggered by scatter factor/hepatocyte growth factor are mediated through the cytoplasmic domain of the c-Met receptor
23. Interleukin 4 inhibits hepatocyte growth factor-induced invasion and migration of colon carcinomas
24. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer
25. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
26. Structure, chromosomal localization, and expression of 12 genes of the MAGE family
27. Expression of MAGE genes in human colorectal carcinoma
28. Expression spectrum of melanoma antigen-encoding gene family members in colorectal carcinoma
29. A molecular strategy for detecting metastatic cancers using multiple tumor-specific MAGE-A genes
30. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow
31. Guanylyl cyelase C messenger RNA is a biomarker for recurrent stage II colorectal cancer
32. Detection of carcinoembryonic antigen messenger RNA in lymph nodes from patients with colorectal cancer